Cargando…

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

Targeted therapies have drastically changed the management of metastatic melanoma and have shown encouraging results on tumour progression but are also known for their high rates of adverse reactions. In general, targeted therapies are contraindicated during pregnancy due to concerns about teratogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Haan, Jorine, van Thienen, Johannes V., Casaer, Michael, Hannivoort, Rebekka A., Van Calsteren, Kristel, van Tuyl, Minke, van Gerwen, Mathilde M., Debeer, Anne, Amant, Frédéric, Painter, Rebecca C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869570/ https://www.ncbi.nlm.nih.gov/pubmed/29606950 http://dx.doi.org/10.1159/000487128

Ejemplares similares

Imaging modalities in pregnant cancer patients
por: Vandecaveye, Vincent, et al.
Publicado: (2021)

Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing
por: Lenaerts, Liesbeth, et al.
Publicado: (2019)

Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
por: Vandenbroucke, Tineke, et al.
Publicado: (2020)

Data describing child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
por: van Gerwen, Mathilde, et al.
Publicado: (2020)

Pregnancy and Cancer: the INCIP Project
por: Maggen, Charlotte, et al.
Publicado: (2020)

Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy
por: Berends, Claudia, et al.
Publicado: (2021)

High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report
por: Amant, Frédéric, et al.
Publicado: (2010)

Managing Side Effects of Vemurafenib Therapy for Advanced Melanoma
por: Hagen, Brenda, et al.
Publicado: (2014)

Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy
por: Maggen, Charlotte, et al.
Publicado: (2019)

From fruitflies to mammals: mechanisms of signalling via the Sonic hedgehog pathway in lung development
por: van Tuyl, Minke, et al.
Publicado: (2000)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review
por: Han, Sileny N, et al.
Publicado: (2012)

Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma
por: Wolf, Sanne EJ, et al.
Publicado: (2013)

Metastatic melanoma and vemurafenib: novel approaches
por: De Mello, Ramon Andrade
Publicado: (2012)

A STATement on Vemurafenib-Resistant Melanoma
por: Hartsough, Edward J., et al.
Publicado: (2013)

Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women
por: Mian, Paola, et al.
Publicado: (2019)

The Tired Pregnant Woman
por: VanNatta, Katie, et al.
Publicado: (2021)

The impact of cancer and chemotherapy during pregnancy on child neurodevelopment: A multimodal neuroimaging analysis
por: Blommaert, J., et al.
Publicado: (2020)

Cognitive and Behavioral Development of 9-Year-Old Children After Maternal Cancer During Pregnancy: A Prospective Multicenter Cohort Study
por: Van Assche, Indra A., et al.
Publicado: (2023)

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
por: Cui, Hongmei, et al.
Publicado: (2021)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance
por: Peng, Jianyu, et al.
Publicado: (2023)

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
por: Osrodek, Marta, et al.
Publicado: (2020)

Sorafenib sensitizes melanoma cells to vemurafenib through ferroptosis
por: Tang, Fengjie, et al.
Publicado: (2020)

Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
por: Kemper, Kristel, et al.
Publicado: (2015)

Long-Term Neurodevelopmental Outcome of Children after in Utero Exposure to Chemotherapy
por: Korakiti, Anna-Maria, et al.
Publicado: (2020)

Pushing the boundaries. Concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy: A case report
por: LeJeune, Charlotte, et al.
Publicado: (2022)

Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
por: Castellani, Elisa, et al.
Publicado: (2012)

Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
por: Hernandez-Davies, Jenny E, et al.
Publicado: (2015)

Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists
por: de Geus, Koen F., et al.
Publicado: (2018)

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
por: van Gerwen, Mathilde, et al.
Publicado: (2021)

Postpartum breast cancer behaves differently
por: Van den Rul, N., et al.
Publicado: (2011)

Proton therapy of a pregnant patient with nasopharyngeal carcinoma
por: Heimovaara, Joosje H., et al.
Publicado: (2022)

Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals
por: Ceulemans, Michael, et al.
Publicado: (2022)

Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing
por: Salton, Maayan, et al.
Publicado: (2015)

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
por: Borch, Troels Holz, et al.
Publicado: (2014)

Dermoscopic assessment of skin toxicities in patients with melanoma during treatment with vemurafenib
por: Rajczykowski, Marcin, et al.
Publicado: (2018)

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells()
por: Mologni, Luca, et al.
Publicado: (2018)

Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
por: Atzori, Maria Grazia, et al.
Publicado: (2019)

RNA sequencing data of Vemurafenib-resistant melanoma cells and parental cells
por: Zhao, Kun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1po6j8ubigol1o04ukjieksj3a